Free Trial

Sensus Healthcare (SRTS) Competitors

Sensus Healthcare logo
$6.56 -0.17 (-2.53%)
As of 01/17/2025 04:00 PM Eastern

SRTS vs. TCMD, DCTH, ZIMV, CVRX, NPCE, SMTI, LUNG, DRTS, ELMD, and ZYXI

Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Tactile Systems Technology (TCMD), Delcath Systems (DCTH), ZimVie (ZIMV), CVRx (CVRX), NeuroPace (NPCE), Sanara MedTech (SMTI), Pulmonx (LUNG), Alpha Tau Medical (DRTS), Electromed (ELMD), and Zynex (ZYXI). These companies are all part of the "medical equipment" industry.

Sensus Healthcare vs.

Tactile Systems Technology (NASDAQ:TCMD) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, community ranking, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

In the previous week, Tactile Systems Technology had 3 more articles in the media than Sensus Healthcare. MarketBeat recorded 5 mentions for Tactile Systems Technology and 2 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.76 beat Tactile Systems Technology's score of 0.74 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tactile Systems Technology
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sensus Healthcare
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 1.4% of Tactile Systems Technology shares are owned by company insiders. Comparatively, 9.4% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Sensus Healthcare has a net margin of 22.54% compared to Tactile Systems Technology's net margin of 5.42%. Sensus Healthcare's return on equity of 17.99% beat Tactile Systems Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Tactile Systems Technology5.42% 9.24% 6.56%
Sensus Healthcare 22.54%17.99%16.26%

Tactile Systems Technology has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tactile Systems Technology$274.42M1.52$28.51M$0.6526.77
Sensus Healthcare$24.41M4.40$490K$0.5711.51

Tactile Systems Technology currently has a consensus target price of $23.00, suggesting a potential upside of 32.18%. Sensus Healthcare has a consensus target price of $12.50, suggesting a potential upside of 90.55%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Sensus Healthcare is more favorable than Tactile Systems Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.67
Sensus Healthcare
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Tactile Systems Technology has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.

Tactile Systems Technology received 195 more outperform votes than Sensus Healthcare when rated by MarketBeat users. Likewise, 70.20% of users gave Tactile Systems Technology an outperform vote while only 68.42% of users gave Sensus Healthcare an outperform vote.

CompanyUnderperformOutperform
Tactile Systems TechnologyOutperform Votes
377
70.20%
Underperform Votes
160
29.80%
Sensus HealthcareOutperform Votes
182
68.42%
Underperform Votes
84
31.58%

Summary

Sensus Healthcare beats Tactile Systems Technology on 9 of the 17 factors compared between the two stocks.

Get Sensus Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRTS vs. The Competition

MetricSensus HealthcareSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$107.52M$4.74B$5.36B$9.09B
Dividend YieldN/A47.30%5.13%4.03%
P/E Ratio11.5126.2989.4717.33
Price / Sales4.4055.841,255.73134.95
Price / Cash113.2650.1443.7535.97
Price / Book2.207.825.324.80
Net Income$490,000.00$14.04M$122.60M$224.91M
7 Day Performance0.31%1.27%0.69%1.77%
1 Month Performance-15.68%8.93%1.55%2.22%
1 Year Performance130.99%52.01%27.25%20.67%

Sensus Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRTS
Sensus Healthcare
3.2121 of 5 stars
$6.56
-2.5%
$12.50
+90.5%
+131.0%$107.18M$24.41M11.5140Short Interest ↑
TCMD
Tactile Systems Technology
3.5105 of 5 stars
$17.20
-0.2%
$23.00
+33.7%
+27.7%$412.75M$285.05M26.46980Analyst Downgrade
Short Interest ↑
News Coverage
Positive News
DCTH
Delcath Systems
3.7192 of 5 stars
$12.79
+11.4%
$21.50
+68.1%
+271.7%$408.90M$2.07M-9.4760Analyst Forecast
Short Interest ↓
News Coverage
Gap Up
High Trading Volume
ZIMV
ZimVie
2.712 of 5 stars
$13.64
+1.1%
$19.50
+43.0%
-14.7%$376.45M$451.29M-1.042,700News Coverage
Positive News
CVRX
CVRx
1.7503 of 5 stars
$15.04
+6.1%
$16.67
+10.8%
-36.8%$364.93M$47.26M-5.57160Upcoming Earnings
Analyst Upgrade
Analyst Revision
News Coverage
High Trading Volume
NPCE
NeuroPace
3.3691 of 5 stars
$12.11
+1.4%
$15.00
+23.9%
-7.9%$361.46M$76.45M-12.11170
SMTI
Sanara MedTech
2.44 of 5 stars
$32.46
+0.7%
$47.00
+44.8%
-13.5%$283.73M$78.06M-32.7960News Coverage
Positive News
LUNG
Pulmonx
2.6093 of 5 stars
$7.05
+4.3%
$12.75
+80.9%
-50.8%$278.39M$79.30M-4.80250News Coverage
DRTS
Alpha Tau Medical
2.1067 of 5 stars
$3.70
+14.6%
$8.00
+116.2%
+27.4%$258.72MN/A-8.6080Short Interest ↑
ELMD
Electromed
N/A$30.47
+2.4%
N/A+223.5%$257.72M$57.06M42.32160
ZYXI
Zynex
3.8324 of 5 stars
$7.77
-0.8%
$14.00
+80.2%
-22.1%$247.44M$193.67M51.801,100Positive News

Related Companies and Tools


This page (NASDAQ:SRTS) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners